跳至主要内容
临床试验/NCT05563883
NCT05563883进行中(未招募)不适用

Atrial Fibrillation and Cancer: a Nationwide French Cohort Study

University Hospital, Caen1 个研究点 分布在 1 个国家目标入组 5,000,000 人开始时间: 2022年9月22日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
5,000,000
试验地点
1
主要终点
cancer

研究概览

简要总结

Atrial fibrillation (AF) is a common complication associated with cancer but the risk of AF according to the cancer localization and status as well as the risk of thromboembolisms, bleedings and mortality are poorly known.

The objective of this study is to use a very large French nationwide cohort to adress thèses questions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult hospitalized patients
  • with an ICD-10 code discharge from january 2010 to december 2019 in the French national hospital discharge database (PMSI Programme de Médicalisation des Systèmes d'Information)

排除标准

  • 未提供

结局指标

主要结局

cancer

时间窗: ffrom inclusion in the cohort up to 10 years

occurrence of cancer

atrial fibrillation

时间窗: from inclusion in the cohort up to 10 years

occurrence of atrial fibrillation

次要结局

  • mortality(from inclusion in the cohort up to 10 years)
  • thromboembolism(from inclusion in the cohort up to 10 years)
  • bleeding(from inclusion in the cohort up to 10 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joachim ALEXANDRE

Prof

University Hospital, Caen

研究点 (1)

Loading locations...

相似试验

Atrial Fibrillation and Cancer: a Nationwide French... | 临床试验